T. Rowe Price Associates’s Nano X Imaging NNOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Buy
45,688
+11,578
+34% +$30.5K ﹤0.01% 2995
2025
Q4
$96K Hold
34,110
﹤0.01% 2953
2025
Q3
$127K Buy
34,110
+1,927
+6% +$8.58K ﹤0.01% 2884
2025
Q2
$167K Buy
32,183
+8,623
+37% +$43.9K ﹤0.01% 2773
2025
Q1
$118K Buy
23,560
+1,570
+7% +$10.9K ﹤0.01% 2786
2024
Q4
$159K Buy
21,990
+4,658
+27% +$29.8K ﹤0.01% 2757
2024
Q3
$106K Hold
17,332
﹤0.01% 2805
2024
Q2
$128K Buy
17,332
+3,616
+26% +$32.2K ﹤0.01% 2709
2024
Q1
$135K Buy
13,716
+1,612
+13% +$12.9K ﹤0.01% 2723
2023
Q4
$78K Buy
12,104
+1,397
+13% +$8.72K ﹤0.01% 2747
2023
Q3
$71K Buy
+10,707
New +$110K ﹤0.01% 2725

Other funds holding NNOX

T. Rowe Price Associates's NNOX Position: Q1 2026 in Review

T. Rowe Price Associates increased its Nano X Imaging (NNOX) stake by 34% in Q1 2026, buying an estimated $30.5K and bringing the position to 45,688 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

T. Rowe Price Associates first reported a position in NNOX in Q3 2023 and has held it in 11 quarters since. The position peaked at $167K in Q2 2025. 126 funds tracked by Wall St. Rank hold NNOX as of Q1 2026.

  • T. Rowe Price Associates held 45,688 shares of Nano X Imaging worth $104K as of Q1 2026.
  • T. Rowe Price Associates bought 11,578 Nano X Imaging shares in Q1 2026, an estimated $30.5K.
  • Nano X Imaging made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2995 holding.
  • T. Rowe Price Associates first reported a position in Nano X Imaging in Q3 2023 and has held it in 11 quarters since.
  • T. Rowe Price Associates's Nano X Imaging position peaked at $167K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Nano X Imaging as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.